NCT01642342 2022-08-24
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
University of Southern California
Phase 1 Terminated
Clinical Trials
10 trialsNCT01573780 2022-08-15
Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Roswell Park Cancer Institute
Phase 1 Terminated
NCT02070406 2019-02-28
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT01705106 2018-05-30
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
University of Chicago
Phase 1 Terminated
NCT01098643 2017-04-04
Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
Vanderbilt University Medical Center
Phase NA Terminated
NCT01324115 2015-03-05
NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
Cancer Research UK
Phase 1 Terminated
NCT00002948 2014-07-02
High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Yale University
Phase 1 Terminated
NCT00003009 2014-05-22
Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
University of Southern California
Phase 1 Terminated
NCT01602627 2013-02-07
Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies
Case Comprehensive Cancer Center
Phase 1 Terminated
NCT01147029 2012-05-01
GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
Cancer Research UK
Phase 1 Terminated